ANALYSIS OF FINANCIAL STATEMENT

Balance sheet As At March 31 2011

Particulars

Schedules

Rs

As
at
31.3.2011 Rs

Rs

As
at
31.3.2010 Rs

Source of funds
Shareholders funds
Capital

500,000,000

500,000,000

Reserves and surplus

2,275,791,688

1,824,554,402

2,775,791,688

2,324,554,402

Total
Application of funds
Fixed assets

Gross block

177,056,599

151,994,567

Less: depreciation

124,447,461

103,764,634

Net block
Capital
progress

work

in

Investments

Deferred tax asset(net)

52,609,138

48,229,933

6,786,254

5,517,305

1,772,969,400

371,464,385

17,670,855

4,822,541

Current assets, loan and

advance
Sundry debtors

111,594,460

167,913,529

Cash and bank balance

1,100,014,984

2,046,273,249

Other current assets

39,081,263

47,651,436

Loans & advance

318,013,328

180,964,971

1,568,704,035

2,442,803,185

Less :current liabilities

and provisions
Current liabilities

283,739,463

215,407,017

Provisions

10

359,208,531

332,875,930

642,947,994

548,282,947

Net current assets

925,756,041

1,894,520,238

Total

2,775,791,688

2,324,554,402

PROFIT AND LOSS ACCOUNT FOR THE YEAR ENDED MARCH 31, 2011
Schedul
Rs
For the year
Rs
es
ended
31.3.2011 Rs
Income
Management fees
2,206,646,200
(gross)[tax
deducted at source
Rs.243,393,103
(previous
year
Rs.213,099,174)]
Portfolio advisory
160,936,141
fee [tax deducted at
source
Rs.18,059
(previous
yearRs.36,298)]
Portfolio
30,022,891
Management Fee [
Tax deducted at
source Rs.632,588
(Previous
year
Rs.1,271,077]
Income
from 11
21,678,304
investments
Other income

12

For the year

ended
31.3.2010 Rs
1,815,674,733

130,489,018

21,964,880

17,948,403

133,138,577
2,552,422,113

171,328,916
2,157,405,950

Employee Costs
13
Administrative and 14
Other Expenses

678,305,452
680,632,431

464,355,867
532,397,781

Depreciation
Fixed Assets

24,436,883

22,196,076

1,383,374,766
1,169,047,347

1,018,949,724
1,138,456,226

EXPENDITURE:

on

Profit before tax

Provision for taxes:
Current Tax
Deferred Tax ( refer
note 5)
Fringe Benefit Tax

(393,420,000)
12,848,314
-

(386,700,000)
2,639,864
2,193,433

Excess
Provision
for Tax in respect of
previous
years
written back
Excess
Provision
for FBT in respect
of
previous
years
written back

Profit after tax

Balance
brought
forward from
previous year
Profit available for
appropriation
APPROPRIATION
S
Transfer to General
Reserve
Interim Dividend
Proposed
Equity
Dividend
Tax on Proposed
Equity Dividend
Excess
provision
for
Dividend
Distribution Tax of
PY written Back
Surplus carried to
Balance Sheet
Basic and diluted
earnings per share
(Face Value per
Share Rs. 100/-)

2,147,720
(380,571,686)

(379,718,983)

788,475,661
1,429,363,841

758,737,243
1,031,414,598

2,217,839,502

1,790,151,841

78,847,566

80,000,000

290,000,000

240,000,000

48,165,375

40,788,000

(927,000)

1,801,753,561

1,429,363,841

2,217,839,502
157.70

1,790,151,841
151.75

Interpretation:
Particular
31.3.2011

31.3.2010

Net present value (NPV )

38.223

35.168

Return on net worth (RONW)

41.088

32.640

Return on capital employee (ROCE)

51.326

47.979

Current ratio (CR)

3.382

1.289

Fixed assets (FA)

2.437

2.235

Earnings per share (EPS)

157.70

151.75

Dividend per share ( DPS)

40

48

An interim Dividend of Rs. 58 per Equity Share, subject to tax, was declared on 28th March,
2011 on the paid-up equity Share capital of the Company, involving a total outgo of Rs. 3,381.65
lacs on account of dividend inclusive of dividend Distribution tax. The Directors recommend that
the Interim Dividend paid during the year, be declared as the Final Dividend for the year 201011.
During the year under review, the Company has not made any fresh issue of capital. However,
consequent upon AMUNDI and Credit Agricole S.A. entering into an agreement to undertake a
global merger of their fundamental asset management businesses, 18, 50,000 equity shares
constituting 37% of the paid-up equity share capital held bySocit Gnrale Asset Management
have been transferred to AMUNDI India Holding, a wholly owned subsidiary of AMUNDI on
30th May, 2011 after obtaining relevant regulatory approvals